Transaction in Own Shares

Summary by AI BETAClose X

Legal & General Group Plc has purchased 7,200,000 of its ordinary shares between March 16th and March 20th, 2026, as part of its share buyback program. These repurchased shares will be cancelled, reducing the total number of ordinary shares in issue to 5,687,553,849, which also represents the total number of voting rights. The purchases were executed through its broker, Barclays Capital Securities Limited, with prices ranging from 236.60 pence to 254.10 pence per share.

Disclaimer*

Legal & General Group Plc
23 March 2026
 

LEGAL & GENERAL GROUP PLC
ISIN: GB0005603997
23rd March 2026

 

LEI number: 213800JH9QQWHLO99821

 

Legal & General Group Plc (the "Company")
Transaction in Own Shares


The Company announces that from 16th March 2026 up to and including 20th March 2026 it had purchased a total of 7,200,000 of its ordinary shares of 2.5 pence each (the "ordinary shares"), through the Company's broker Barclays Capital Securities Limited as detailed below. The repurchased ordinary shares will be cancelled.

Date

Aggregate number of ordinary shares purchased

Highest price paid (per ordinary share)

Lowest price paid (per ordinary share)

Volume weighted average price

 

Trading venue

16th March 2026

589,289

249.40

244.60

247.25

XLON

16th March 2026

190,129

249.40

244.20

247.28

BATE

16th March 2026

254,676

249.40

244.20

246.96

TRQX

16th March 2026

117,580

249.20

244.50

247.34

AQXE

16th March 2026

348,326

249.40

244.40

247.17

CHIX

17th March 2026

599,861

252.00

247.90

250.53

XLON

17th March 2026

181,610

252.00

247.90

250.76

BATE

17th March 2026

230,610

252.00

247.90

250.63

TRQX

17th March 2026

161,373

252.00

247.90

250.28

AQXE

17th March 2026

326,546

252.00

247.90

250.66

CHIX

18th March 2026

446,333

254.10

250.60

252.44

XLON

18th March 2026

215,469

254.10

250.60

252.24

BATE

18th March 2026

229,307

254.10

250.40

252.23

TRQX

18th March 2026

133,440

254.10

250.90

252.24

AQXE

18th March 2026

375,451

254.10

250.40

252.27

CHIX

19th March 2026

324,727

248.00

241.90

243.68

XLON

19th March 2026

278,893

247.10

241.70

243.59

BATE

19th March 2026

293,315

247.10

241.70

243.58

TRQX

19th March 2026

129,587

247.00

241.70

243.77

AQXE

19th March 2026

373,478

248.00

241.50

243.93

CHIX

20th March 2026

352,468

244.40

236.60

240.85

XLON

20th March 2026

251,471

244.10

236.60

240.09

BATE

20th March 2026

283,028

244.30

236.60

240.97

TRQX

20th March 2026

138,110

244.00

236.60

240.37

AQXE

20th March 2026

374,923

244.40

236.60

240.86

CHIX


The purchases form part of the Company's share buyback programme announced on 11th March 2026.

Following settlement of the above purchases and cancellation of the purchased ordinary shares, the Company's total number of ordinary shares in issue shall be 5,687,553,849 ordinary shares.

No ordinary shares are held in treasury. Therefore, the total number of voting rights in the Company is 5,687,553,849.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as incorporated into and implemented under English law (including by virtue of the European Union (Withdrawal) Act 2018), the detailed breakdown of individual trades made by Barclays Capital Securities Limited on behalf of the Company as part of the share buyback programme is set out below.

http://www.rns-pdf.londonstockexchange.com/rns/7538X_1-2026-3-23.pdf

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings